Stay updated on Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedMelanoma is added as a related topic. MedlinePlus Genetics is listed under related topics to provide cross-references to condition information.SummaryDifference0.1%

- Check15 days agoChange DetectedLocation entries just for Chile are updated to change how regional name text is displayed (e.g., removing the “Región de …” wording while keeping the same city/region information). The page revision/build identifier is also updated.SummaryDifference0.3%

- Check22 days agoChange DetectedLocation entry for Italy changed from Padua, Italy, 35128 to Padova, Italy, 35128. The page revision was updated to v3.5.2.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded Naples, Italy, 80131 as a trial site. Removed Napoli, Italy, 80131 and Melanoma and MedlinePlus Genetics-related topics from the related topics section.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check58 days agoChange DetectedMelanoma and related topics, including MedlinePlus Genetics, were added; the page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.